Former Sen Finance Committee Investigator Speaks Out
"What’s gone on with the pharmaceutical industry is a physician arms race to buy off doctors…"
Research Integrity: Don’t Mess With the DSMB
"The current way that DSMBs are constituted and report has resulted in a loss of faith." NEJM
Anesthesiologist who Committed Major Fraud Claims Bipolar Defense
"He was one of the most prolific investigators in the area of postoperative pain management. His fraud sets back our knowledge in the field tremendously.” Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia.
Devastating FDA Safety Review of Avandia
Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
Corrupted Science–BMJ Review Examines Avandia Literature
Dr Mark Stolar, professor of clinical medicine at Northwestern: "There are very few people in whom I don’t detect bias based on where their conflicts lie.”
Avandia Face-Off_GSK–Dr. Steven Nissen
GSK Executives: "frankly, the last thing we want to do is get into a public debate about whose analysis is right."
Avandia, a Case of Deja Vu all over again
Even worse, FDA officials, in collusion and collaboration with GSK, approved an unethical and exploitative clinical trial—TIDE, which is on-going.
GMC Damning Wakefield Verdict Does Not Address Autism-Vaccine Validity
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
Eli Lilly Exec Heads to Harvard Medical School
"Does this appointment signify that Harvard Medical School intends to even further strengthen its research ties to the pharmaceutical industry?"
An Ethically Dubious Blood Experiment: RECESS
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
JAMA Antidepressant Meta-analysis Reveals 22 Years of Deception
Twenty-two years after the US marketing of Prozac, JAMA meta-analysis shows antidepressants to be worthless for most of the people for whom they are prescribed.
Follow-up: Antipsychotics–Psychiatry’s Disregard for the life-threatening hazards
Corporate business ethics and investors’ interests have swept aside the humanitarian foundation of American medicine and most of related healthcare, and caring service professions.